Information for "Nintedanib plus mFOLFOX6 while secondline management of metastatic chemorefractory intestines cancers The randomised placebocontrolled stage II TRICCC examine AIOKRK0111"
From EECH Central
Basic information
Display title | Nintedanib plus mFOLFOX6 while secondline management of metastatic chemorefractory intestines cancers The randomised placebocontrolled stage II TRICCC examine AIOKRK0111 |
Default sort key | Nintedanib plus mFOLFOX6 while secondline management of metastatic chemorefractory intestines cancers The randomised placebocontrolled stage II TRICCC examine AIOKRK0111 |
Page length (in bytes) | 3,481 |
Page ID | 1396238 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Harborarmy5 (Talk | contribs) |
Date of page creation | 09:00, 23 April 2024 |
Latest editor | Harborarmy5 (Talk | contribs) |
Date of latest edit | 09:00, 23 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |